Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway-Reference-Cited by-同舟云学术

Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway

Published:2022-07-28 Issue:6 Volume:56 Page:989-1006
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Zhao Mirabella¹²^ORCID,Lirhus Sandre³,Lördal Mikael⁴,Langholz Ebbe⁵⁶,Knudsen Torben⁷⁸,Voutilainen Markku⁹,Høivik Marte Lie¹⁰¹¹^ORCID,Moum Bjorn¹⁰¹¹,Anisdahl Karoline¹⁰¹¹^ORCID,Sæbø Borghild¹²,Haiko Paula¹³,Malmgren Carolina¹⁴,Coskun Mehmet¹⁵,Melberg Hans Olav³,Burisch Johan¹²^ORCID

Affiliation:

1. Gastrounit, Medical Division Copenhagen University Hospital ‐ Amager and Hvidovre Hvidovre Denmark

2. Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults Copenhagen University Hospital ‐ Amager and Hvidovre Hvidovre Denmark

3. Department of Health Management and Health Economics Institute of Health and Society, University of Oslo Oslo Norway

4. Division of Gastroenterology and Hepatology, Department of Medicine Danderyds Hospital Stockholm Sweden

5. Gastro Unit, Medical Division Herlev University Hospital Herlev Denmark

6. Institute for Clinical Medicine University of Copenhagen Copenhagen Denmark

7. Department of Medicine Hospital of South West Denmark Esbjerg Denmark

8. Department of Regional Health Research University of Southern Denmark Odense Denmark

9. Department of Gastroenterology University of Turku and Turku University Hospital Turku Finland

10. Department of Gastroenterology Oslo University Hospital Oslo Norway

11. Institute of Clinical Medicine University of Oslo Oslo Norway

12. Takeda AS, Medical Affairs Asker Norway

13. Takeda Oy, Medical Affairs Helsinki Finland

14. Takeda Pharma AB, Medical Affairs Stockholm Sweden